KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test
Introduction
The KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test is a revolutionary diagnostic tool that plays a pivotal role in the management of acute myelogenous leukemia (AML). This test utilizes Next Generation Sequencing (NGS) technology to analyze the KRAS gene, which is known to be a significant factor in the development and progression of various cancers, including leukemia. Understanding the genetic mutations in the KRAS gene can provide critical insights into the disease, guiding treatment decisions and improving patient outcomes.
What the Test Measures
This genetic test specifically measures mutations within the KRAS gene, which can influence the behavior of leukemia cells and their response to certain therapies. By identifying these mutations, healthcare providers can tailor treatment plans to the individual needs of the patient, ensuring more effective management of the disease.
Who Should Consider This Test
The KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test is recommended for:
- Individuals diagnosed with acute myelogenous leukemia.
- Patients with a family history of KRAS-related cancers.
- Those experiencing symptoms such as fatigue, frequent infections, or unexplained bleeding.
- Patients considering targeted therapies that may be influenced by KRAS mutations.
Benefits of Taking the Test
Taking the KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test offers several benefits:
- Accurate identification of genetic mutations that could affect treatment options.
- Personalized treatment plans based on genetic findings.
- Improved monitoring of disease progression and response to therapy.
- Enhanced understanding of familial cancer risks for better preventive measures.
Understanding Your Results
Results from the KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test will be discussed in detail with your healthcare provider. They will explain the significance of any mutations found, how they may impact your treatment options, and what steps to take next. It is essential to interpret these results within the context of your overall clinical picture.
Test Pricing
Test Name | Discount Price (NGN) | Regular Price (NGN) |
---|---|---|
KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today!
Don’t wait to gain valuable insights into your health. Book the KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test today for only 400,000 NGN. Call or WhatsApp us at +2348077798758 to schedule your appointment and take the first step towards personalized cancer care.
Test Specifications
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
- Pre-test Instructions: Clinical History of Patient who is going for KRAS Gene Leukemia, acute myelogenous NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KRAS Gene Leukemia.
- Specialty: Oncologist
- Department: Genetics
- Method: NGS Technology
- Disease Type: Cancer